公司资料

Abeona Therapeutics 股价、新闻与催化剂

股票代码:: ABEO
交易所:: NASDAQ
行业:: Biopharma
所在地:: United States

股票表现

5.94 USD (-0.75%)

收盘价

最后更新: 2026年8月17日

324M USD

市值

股价为何变动

As of Aug 17, 2026, ABEO closed down 0.75% at $5.94. No new same-company headline was identified in the current news window.

公司概览

Cell and Gene Therapy Company

Abeona Therapeutics develops and commercializes genetic medicines for serious diseases.

ZEVASKYN

ZEVASKYN is an autologous, gene-corrected epidermal sheet therapy for wounds in recessive dystrophic epidermolysis bullosa and provides Abeona with a commercial cell-therapy platform.

ABO-701

ABO-701 is an engineered T-cell program targeting PSMA in solid tumors and uses synthetic immune-receptor technology intended to improve selectivity and activity.